FGF23 induces hypertrophic growth of cultured cardiac myocytes via FGFR4, and deletion or blockade of FGFR4 in CKD rodent models with elevated FGF23 protects from cardiac hypertrophy [23]. This evidence concerns the gene FGFR4 and chronic kidney disease.